title: Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications.
authors.forename: F
authors.initials: F
authors.lastname: Lauria
authors.forename: M
authors.initials: M
authors.lastname: Bocchia
authors.forename: G
authors.initials: G
authors.lastname: Marotta
authors.forename: D
authors.initials: D
authors.lastname: Raspadori
authors.forename: P L
authors.initials: PL
authors.lastname: Zinzani
authors.forename: D
authors.initials: D
authors.lastname: Rondelli
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017338:Cladribine / Q000008:administration & dosage* / Q000009:adverse effects; D003141:Communicable Diseases / Q000209:etiology; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007943:Leukemia, Hairy Cell / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D017338:Cladribine